PainChek Limited
ASX:PCK.AX
0.031 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.672 | 1.95 | 0.979 | 0.215 | 0.248 | 0.215 | 0.051 | 0.031 | 0.004 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.945 | 1.237 | 1.237 | 0.639 | 0.265 | 0 | 1.71 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.727 | 0.713 | -0.259 | -0.424 | -0.017 | 0.215 | -1.659 | 0.031 | 0.004 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.272 | 0.365 | -0.264 | -1.975 | -0.068 | 1 | -32.753 | 0.995 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 4.571 | 3.817 | 2.351 | 2.652 | 2.27 | 1.895 | 1.699 | 0.821 | 0.084 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 2.91 | 3.033 | 2.665 | 3.612 | 2.584 | 1.486 | 1.184 | 3.01 | 1.092 | 0.698 | 0.39 | 0.439 | 0.27 |
| Selling & Marketing Expenses
| 2.049 | 1.858 | 1.655 | 1.571 | 1.261 | 0.729 | 0.319 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.67 | 5.657 | 4.98 | 5.893 | 12.753 | 2.329 | 1.862 | 3.01 | 1.092 | 0.698 | 0.39 | 0.439 | 0.27 |
| Other Expenses
| 0 | 1.181 | 1.853 | 2.887 | 2.599 | 0.745 | 0.41 | -4.5 | 0.083 | 0.006 | 0.416 | 0.022 | 0.155 |
| Operating Expenses
| 10.241 | 9.475 | 7.331 | 8.545 | 15.023 | 3.478 | 3.152 | 4.005 | 1.407 | 0.981 | 0.806 | 1.181 | 0.425 |
| Operating Income
| -9.514 | -8.762 | -7.589 | -8.969 | -15.04 | -3.262 | -4.811 | -4.005 | -1.407 | -0.981 | -0.806 | -1.181 | -0.425 |
| Operating Income Ratio
| -3.561 | -4.494 | -7.756 | -41.757 | -60.6 | -15.141 | -94.982 | -128.715 | -361.627 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.206 | 0.139 | 0.776 | 1.847 | 1.849 | 0.08 | -0 | -4.5 | 0.083 | 0.006 | 0.014 | 0.022 | 0.019 |
| Income Before Tax
| -8.308 | -8.623 | -6.813 | -7.122 | -13.191 | -3.262 | -4.811 | -8.474 | -1.681 | -0.974 | -0.792 | -1.099 | -0.406 |
| Income Before Tax Ratio
| -3.109 | -4.423 | -6.962 | -33.157 | -53.15 | -15.141 | -94.982 | -272.329 | -431.859 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -1.206 | -1.049 | -1.093 | -1.058 | -0.799 | -0.745 | 0 | -0.031 | 3.807 | 0.729 | 0 | -0.06 | 0 |
| Net Income
| -8.308 | -7.575 | -5.721 | -6.064 | -12.393 | -3.262 | -4.811 | -8.474 | -5.047 | -1.704 | -0.792 | -1.099 | -0.406 |
| Net Income Ratio
| -3.109 | -3.885 | -5.846 | -28.23 | -49.931 | -15.141 | -94.982 | -272.329 | -1,296.878 | 0 | 0 | 0 | 0 |
| EPS
| -0.006 | -0.006 | -0.005 | -0.005 | -0.013 | -0.004 | -0.006 | -0.016 | -0.037 | -0.041 | -0.043 | -0.061 | -0.041 |
| EPS Diluted
| -0.006 | -0.006 | -0.005 | -0.005 | -0.013 | -0.004 | -0.006 | -0.016 | -0.037 | -0.041 | -0.043 | -0.061 | -0.041 |
| EBITDA
| -8.282 | -8.745 | -7.575 | -8.91 | -14.997 | -3.259 | -4.806 | -4.005 | -1.293 | -0.934 | -0.78 | -1.155 | -0.424 |
| EBITDA Ratio
| -3.1 | -4.486 | -7.741 | -41.48 | -60.426 | -15.127 | -94.902 | -128.71 | -332.348 | 0 | 0 | 0 | 0 |